Glucose control and vascular complications in veterans with type 2 diabetes

Duckworth, William, Abraira, Carlos, Moritz, Thomas, Reda, Domenic, Emanuele, Nicholas, Reaven, Peter D., Zieve, Franklin J., Marks, Jennifer +8 more·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0808431

Cited by (1,057)

Items 701–800 of 1,057

Effects of insulin resistance on endothelial progenitor cells and vascular repair
Richard M. Cubbon, Matthew Kahn, Stephen Bentley Wheatcroft · 2009 · Clinical Science
Cardiovascular risk in double diabetes mellitus—when two worlds collide
Stephen J. Cleland · 2012 · Nature Reviews Endocrinology
Characteristics of Peripheral Arterial Disease and Its Relevance to the Diabetic Population
Ezio Faglia · 2011 · The International Journal of Lower Extremity Wounds
Diabetes & coronary heart disease: Current perspectives
Mohammed Kumail Ali, K.M. Venkat Narayan, Nikhil Tandon · 2010 · The Indian Journal of Medical Research
Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study
Daniel Martínez-Laguna, Cristian Tebé, M K Javaid, Xavier Nogués, Nigel Arden, Cyrus C. Cooper, Adolfo Díez‐Pérez, Daniel Prieto‐Alhambra · 2014 · Osteoporosis International
Diabetes in the Elderly
Graydon S. Meneilly, Aileen Knip, Daniel Tessier · 2013 · Canadian Journal of Diabetes
Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study
Bethany Warren, Casey M. Rebholz, Yingying Sang, Alexandra K. Lee, Josef Coresh, Elizabeth Selvin, Morgan Erika Grams · 2018 · Diabetes Care
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community
Adam J. Nelson, Neha Jadeja Pagidipati, Vanita R. Aroda, Matthew Aaron Cavender, Jennifer B. Green, Renato D. Lópes, Hussein R. Al‐Khalidi, Tanya Gaynor, Lisa A. Kaltenbach, Julienne K. Kirk et al. · 2021 · Circulation
Management of Type 2 Diabetes Mellitus in Older Adults
Kyung‐Soo Kim, Soo Kyung Kim, Kyung Mi Sung, Yong‐Wook Cho, Seok Won Park · 2012 · Diabetes & Metabolism Journal
Diabetes and Cardiovascular Disease: Changing the Focus from Glycemic Control to Improving Long-Term Survival
Cecilia C. Low Wang, Jane E.B. Reusch · 2012 · The American Journal of Cardiology
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
Yoko Noda, Toru Miyoshi, Hiroki Oe, Yuko Ohno, Kazufumi Nakamura, Norihisa Toh, Kunihisa Kohno, Hiroshi Morita, KENGO FUKUSHIMA KUSANO, Hiroshi Ito · 2013 · Cardiovascular Diabetology
Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia
Itamar Raz, Antonio Ceriello, Peter W.F. Wilson, Chakib Battioui, Eric Wen Su, Lisa Kerr, Cate A. Jones, Zvonko Miličević, Scott J. Jacober · 2011 · Diabetes Care
SGLT2 inhibitors in the management of type 2 diabetes
R. P. Monica Reddy, Silvio E. Inzucchi · 2016 · Endocrine
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes
Setor Kwadzo Kunutsor, Victoria G. Balasubramanian, Francesco Zaccardi, Clare Gillies, Vanita R. Aroda, Samuel Seidu, Kamlesh Khunti · 2024 · Diabetes Obesity and Metabolism
Legacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials
Patrick T. Murray, G. Chune, Vasudevan A. Raghavan · 2010 · Current Atherosclerosis Reports
Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus
N. Wah Cheung, JENNIFER J. CONN, Michael C dʼEmden, Jenny Elizabeth Gunton, Alicia Josephine Jenkins, Glynis P. Ross, Ashim Kumar Sinha, Sofianos Andrikopoulos, Stephen Colagiuri, Stephen Morris Twigg · 2009 · The Medical Journal of Australia
Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD
Sankar Dass Navaneethan, Jesse D. Schold, Stacey E. Jolly, Susana Arrigain, Wolfgang C. Winkelmayer, Joseph V. Nally · 2017 · American Journal of Kidney Diseases
Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer
A. S. Abdelmoneim, Dean T. Eurich, Peter E. Light, Peter Alexander Senior, John M. Seubert, Mark J. Makowsky, Scot H. Simpson · 2015 · Diabetes Obesity and Metabolism
Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease
Jaskanwal Deep Singh Sara, Riad Taher, Nikhil Kolluri, Adrian V Vella, Lilach O. Lerman, Amir Lerman · 2019 · Cardiovascular Diabetology
Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function
Christianne L. Roumie, Jonathan Chipman, Jea Young Min, Amber J. Hackstadt, Adriana M. Hung, Robert A. Greevy, Carlos G. Grijalva, Tom A. Elasy, Marie R. Griffin · 2019 · JAMA
Advances in the management of type 2 diabetes in adults
Rodolfo Javier Galindo, Jennifer M. Trujillo, Cecilia C. Low Wang, Rozalina G. McCoy · 2023 · BMJ Medicine
Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies
Richard E. Pratley, Thérèse McCall, Penny R. Fleck, Craig Wilson, Qais A. Mekki · 2009 · Journal of the American Geriatrics Society
Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
John M. Lachin, Giancarlo C. Viberti, Bernard Zinman, Steven M. Haffner, R. Paul Aftring, Gitanjali Paul, Barbara G. Kravitz, William H. Herman, Rury R. Holman, Steven E. Kahn · 2011 · Clinical Journal of the American Society of Nephrology
Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes
Fukashi Ishibashi, Miki Taniguchi, Aiko Kosaka, Harumi Uetake, Mitra Tavakoli · 2018 · Diabetes Care
Increased risk of severe hypoglycemic events before and after cardiovascular outcomes in TECOS suggests an at-risk type 2 diabetes frail patient phenotype
Standl, Eberhard, Stevens, Susanna R., Armstrong, Paul W., Buse, John B., Chan, Juliana C.N., Green, Jennifer B., Lachin, John M., Scheen, Andre, Travert, Florence, Van de Werf, Frans et al. · 2018 · Diabetes Care
Proinflammatory and Prothrombotic Effects of Hypoglycemia
Paresh Dandona, Ajay Chaudhuri, Sandeep Dhindsa · 2010 · Diabetes Care
Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes
Walz, Lotta, Pettersson, Billie, Rosenqvist, Ulf, Deleskog, Anna, Journath, Gunilla, Wändell, Per · 2014 · Patient Preference and Adherence
Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study
Francesco Zaccardi, Melanie Jane Davies, Nafeesa N Dhalwani, David R. Webb, Gemma Housley, Dominick E. Shaw, James W. Hatton, Kamlesh K. Khunti · 2016 · The Lancet Diabetes & Endocrinology
Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes
Theodore Mazzone · 2010 · Circulation
Association between HbA1c variability and mortality in patients with type 2 diabetes
Toshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, Masatoshi Kikuchi, Shoji Kawazu · 2014 · Journal of Diabetes and its Complications
The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus
Gareth R. Dutton, Cora Elizabeth Lewis · 2015 · Progress in Cardiovascular Diseases
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
Jae‐Seung Yun, Seung‐Hyun Ko · 2016 · Diabetes & Metabolism Journal
Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects
Jin, Sang-Man, Kim, Tae-Hun, Bae, Ji Cheol, Hur, Kyu Yeon, Lee, Myung-Shik, Lee, Moon-Kyu, Kim, Jae Hyeon · 2014 · Diabetes Research and Clinical Practice
Age-related differences in glycaemic control in diabetes
Elizabeth Selvin, Christina M. Parrinello · 2013 · Diabetologia
Association Between Triglyceride Level and Glycemic Control Among Insulin-Treated Patients With Type 2 Diabetes
Deqiang Zheng, Jingtao Dou, Guangxu Liu, Yuesong Pan, Yuxiang Yan, Fen Liu, Herbert Y. Gaisano, Juming Lu, Yan Ling He · 2018 · The Journal of Clinical Endocrinology & Metabolism
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications
David S.H. Bell, Edison Gonçalves · 2019 · Diabetes Obesity and Metabolism
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim et al. · 2024 · Diabetes & Metabolism Journal
Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR
Guntram Schernthaner · 2010 · Wiener Medizinische Wochenschrift
The Kidney in Type 2 Diabetes Therapy
Hiddo J.L. Heerspink, Dick de Zeeuw · 2011 · The Review of Diabetic Studies
Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?
Manuel Serrano‐Gil, Stephan Jacob · 2010 · Advances in Therapy
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
Andreas Holstein, Claude Hammer, Michael Hahn, N. S. A. Kulamadayil-Heidenreich, Peter Louis Kovacs · 2010 · Expert Opinion on Drug Safety
Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
Boaz Hirshberg, Itamar Raz · 2011 · Diabetes Care
Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries
Juan Rosas Guzmán, Ruy Lyra, Carlos Alberto Aguilar-Salinas, Saulo Montenegro Cavalcanti, Felix Escaño, Marcos Tambasia, Elizabeth da Rosa Duarte · 2010 · Revista Panamericana de Salud Pública
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, Tiago F. Outeiro, Zane Jaunmuktane, Thomas T. Warner · 2022 · Movement Disorders
Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy
Philip Hooper, Marie Carole Boucher, Alan F. Cruess, Keith G. Dawson, Walter Delpero, Mark D.J. Greve, Vladimír Kožoušek, Wai‐Ching Lam, David Maberley · 2012 · Canadian Journal of Ophthalmology
Management of diabetes mellitus in older people with comorbidities
Elbert S. Huang · 2016 · BMJ
The Landscape of Diabetic Kidney Disease in the United States
Obidiugwu Kenrik Duru, Tim R. Middleton, Mona K. Tewari, Keith C. Norris · 2018 · Current Diabetes Reports
Cardiovascular Disease in Diabetes Mellitus
Magdalene Szuszkiewicz-Garcia, Jaime A. Davidson · 2013 · Endocrinology and Metabolism Clinics of North America
Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Dong, Yajie, Lv, Qingguo, Li, Sheyu, Wu, Yuan, Li, Ling, Li, Juan, Zhang, Fang, Sun, Xin, Tong, Nanwei · 2017 · Clinics and Research in Hepatology and Gastroenterology
Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus
Florah Tshepo Moshapa, Kirsten Riches‐Suman, Timothy M. Palmer · 2019 · Cardiology Research and Practice
The Assessment of Glycemic Variability and Its Impact on Diabetes-Related Complications: An Overview
Christian Weber, Oliver Schnell · 2009 · Diabetes Technology & Therapeutics
Diabetes Medication Assistance Service: The pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia
Bernadette Mitchell, Carol Lyn Armour, Mary Lee, Yun Ju Christine Song, Kay Stewart, Gregory Mark Peterson, Jeff Hughes, Lorraine D. Smith, Ines Krass · 2011 · Patient Education and Counseling
Expanded Granulocyte/Monocyte Compartment in Myeloid-Specific Triple FoxO Knockout Increases Oxidative Stress and Accelerates Atherosclerosis in Mice
Kyoichiro Tsuchiya, Marit Westerterp, Andrew James Murphy, Vidya Subramanian, Anthony W. Ferrante, Alan R. Tall, Domenico Accili · 2013 · Circulation Research
Hemoglobin A 1c Is Associated With Increased Risk of Incident Coronary Heart Disease Among Apparently Healthy, Nondiabetic Men and Women
Jennifer K. Pai, Leah E. Cahill, Frank B. Hu, Kathryn M. Rexrode, JoAnn Elisabeth Manson, Eric B. Rimm · 2013 · Journal of the American Heart Association
Development of glucose-responsive ‘smart’ insulin systems
Nischay K. Rege, Nelson F. B. Phillips, Michael Aaron Weiss · 2017 · Current Opinion in Endocrinology Diabetes and Obesity
Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?
Nikolaus Marx, Darren K. McGuire, Vlado Perkovic, Hans‐Juergen Woerle, Uli C. Broedl, Maximilian von Eynatten, Jyothis Thomas George, Julio Rosenstock · 2017 · Diabetes Care
Cardiovascular Disease and Diabetic Kidney Disease
Muhammad Maqbool, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm · 2018 · Seminars in Nephrology
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Raz, Itamar · 2013 · Diabetes Care
Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes
Khunti, Kamlesh, Alsifri, Saud, Aronson, Ronnie, Cigrovski Berković, Maja, Enters-Weijnen, Catherine, Forsén, Tom, Galstyan, Gagik, Geelhoed-Duijvestijn, Petronella, Goldfracht, Margalit, Gydesen, Helge et al. · 2017 · Diabetes Research and Clinical Practice
Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications
Poojitha Rajasekar, Christina L. O’Neill, Lydia Eeles, Alan W. Stitt, Reinhold J. Medina · 2015 · Journal of Diabetes Research
Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal
André Jacques Scheen, Bernard H. Charbonnel · 2014 · Diabetes & Metabolism
Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes
Sang Soo Kim, Jong Ho Kim, In Joo Kim · 2016 · Endocrinology and Metabolism
Cardiovascular Protection in People With Diabetes
James A. Stone, Robyn L. Houlden, Peter Lin, Jacob Allen Udell, Subodh Verma · 2018 · Canadian Journal of Diabetes
Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus
Yabing Chen, Xinyang Zhao, Hui Wu · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes
Ofri Mosenzon, Stefano Del Prato, Meir Schechter, Lawrence A. Leiter, Antonio Ceriello, Ralph Anthony DeFronzo, Itamar Raz · 2021 · Cardiovascular Diabetology
Type 2 Diabetes
Sandeep S. Vijan · 2019 · Annals of Internal Medicine
Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?
Maria Camila Pérez-Matos, Martha Catalina Morales Alvarez, Carlos Olimpo Mendivil · 2017 · Journal of Diabetes Research
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Taichi Nagahisa, Yoshifumi Saisho · 2019 · Diabetes Therapy
Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney disease
Kuo, I-Ching, Lin, Hugo You-Hsien, Niu, Sheng-Wen, Hwang, Daw-Yang, Lee, Jia-Jung, Tsai, Jer-Chia, Hung, Chi-Chih, Hwang, Shang-Jyh, Chen, Hung-Chun · 2016 · Scientific Reports
Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better?
Yuanhui Zhang, Rozalina G. McCoy, Jennifer E. Mason, Steven A. Smith, Nilay D. Shah, Brian T. Denton · 2014 · Diabetes Care
New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
Claire C. J. Dekkers, Ron T. Gansevoort, Hiddo J.L. Heerspink · 2018 · Current Diabetes Reports
Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
Segar, Matthew W., Patel, Kershaw V., Vaduganathan, Muthiah, Caughey, Melissa C., Butler, Javed, Fonarow, Gregg C., Grodin, Justin L., McGuire, Darren K., Pandey, Ambarish · 2020 · Diabetes Care
Insulin Resistance, Obesity, and Lipotoxicity
Dilek Yazıcı, Selin Çakmak Demir, Havva Sezer · 2024 · Advances in experimental medicine and biology
The glucose triad and its role in comprehensive glycaemic control: current status, future management
Antonio Ceriello · 2010 · International Journal of Clinical Practice
Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial
Annelli Sandbæk, Simon J. Griffin, Stephen J. Sharp, Rebecca K. Simmons, Knut Borch‐Johnsen, Guy E.H.M. Rutten, Maureen van den Donk, Nicholas J. Wareham, Torsten Lauritzen, Melanie Jane Davies et al. · 2014 · Diabetes Care
Glycemic Control and Risk of Cardiovascular Disease Hospitalization and All-Cause Mortality
Gregory A. Nichols, Sandra Joshua-Gotlib, Shreekant V. Parasuraman · 2013 · Journal of the American College of Cardiology
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes
Aslam Amod · 2012 · Journal of Endocrinology Metabolism and Diabetes of South Africa
The Global Burden of Diabetes
Jessica L. Harding, Mary Beth Weber, Jonathan E. Shaw · 2024 · Wiley eBooks
Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2
Francesco Maranta, Lorenzo Cianfanelli, Domenico Cianflone · 2020 · Advances in experimental medicine and biology
Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019
Jedidiah I Morton, Peter Anthony Lazzarini, Jonathan E. Shaw, Dianna J. Magliano · 2022 · Diabetes Care
Exploring the inhibitory mechanism of p-coumaric acid on α-amylase via multi-spectroscopic analysis, enzymatic inhibition assay and molecular docking
Yanyi Huang, Lloyd Condict, Samantha J. Richardson, Charles Stephen Brennan, Stefan Kasapis · 2023 · Food Hydrocolloids
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
Faramarz Ismail‐Beigi, Timothy E. Craven, Patrick J. O’Connor, Diane M. Karl, Jorge Calles-Escandón, IRENE M. HRAMIAK, SAUL M. GENUTH, William C. Cushman, Hertzel C. Gerstein, Jeffrey L. Probstfield et al. · 2011 · Kidney International
Cardiovascular Comorbidities of Type 2 Diabetes Mellitus: Defining the Potential of Glucagonlike peptide–1-Based Therapies
ROBERT J. CHILTON, Jamison Wyatt, Shailesh Nandish, RENE A. OLIVEROS, Michael Lujan · 2010 · The American Journal of Medicine
Type 2 diabetes mellitus—current therapies and the emergence of surgical options
Harold E. Lebovitz · 2011 · Nature Reviews Endocrinology
Herbal Medicines for the Management of Diabetes
George Qian Li, Antony Kam, Ka Ho Wong, Xian Liang Zhou, Eshaifol Azam Omar, Ali Saeed Alqahtani, Kong M. Li, Valentina Razmovski‐Naumovski, Kelvin Chan · 2012 · Advances in experimental medicine and biology
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Qingguo, Li, Xuan, Liu, Jia, Sun, Xiaodong, Rousselle, Thomas, Ren, Di, Tong, Nanwei, Li, Ji · 2019 · Bioscience Reports
Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes
Eberhard Standl, Oliver Schnell, Darren K. McGuire, Antonio Ceriello, Lars Rydén · 2017 · The Lancet Diabetes & Endocrinology
The Different Roles of miRNA-92a-2-5p and let-7b-5p in Mitochondrial Translation in db/db Mice
Huaping Li, Beibei Dai, Jiahui Fan, Chen Chen, Xiang Nie, Zhongwei Yin, Yanru Zhao, Xudong Zhang, Dao Wen Wang · 2019 · Molecular Therapy — Nucleic Acids
Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy
Triantafyllos Didangelos, Eleni Karlafti, Evangelia Kotzakioulafi, Zisis Kontoninas, Charalampos Margaritidis, Parthena Giannoulaki, Kοnstantinos Kantartzis · 2020 · Nutrients
The role of sulfonylureas in the treatment of type 2 diabetes
Brian Tomlinson, Nivritti G. Patil, Manson Fok, Paul Chan, Christopher Wai Kei Lam · 2021 · Expert Opinion on Pharmacotherapy
Metabolic Memory and Individual Treatment Aims in Type 2 Diabetes – Outcome-Lessons Learned from Large Clinical Trials
Cristina Bianchi, Stefano Del Prato · 2011 · The Review of Diabetic Studies
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
Yoshifumi Saisho · 2014 · Journal of Clinical Medicine
Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys)
Carole Pornet, Isabelle Bourdel‐Marchasson, Pierre Lecomte, É. Eschwège, Isabelle Romon, Sandrine Fosse‐Edorh, F. Assogba, Candice Roudier, Anne Fagot‐Campagna · 2011 · Diabetes & Metabolism
Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications
Richard M. Bergenstal, Clifford J. Bailey, David M. Kendall · 2010 · The American Journal of Medicine
PPAR agonists for the treatment of cardiovascular disease in patients with diabetes
John P.H. Wilding · 2012 · Diabetes Obesity and Metabolism
Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
Graham S. Hillis, Jun Hata, Mark Woodward, Vlado Perkovic, Hisatomi Arima, Clara Kayei Chow, Sophia Zoungas, Anushka A Patel, Neil R Poulter, Giuseppe Mancia et al. · 2012 · Journal of the American Heart Association
Cellular and molecular mechanisms of diabetic glomerulopathy
Luigi Gnudi · 2012 · Nephrology Dialysis Transplantation
Current Antihyperglycemic Treatment Guidelines and Algorithms for Patients with Type 2 Diabetes Mellitus
Lawrence Blonde · 2010 · The American Journal of Medicine
Metabolic Syndrome and Cardiometabolic Risk Factors
Emilia Papakonstantinou, Vaia Lambadiari, George Dimitriadis, Antonis Zampelas · 2014 · Current Vascular Pharmacology